AMEDIN

This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.

Active ingredients

The drug AMEDIN contains one active pharmaceutical ingredient (API):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2110	Tablet	Amedin 5 mg Tablets TAB 5 mg 2 x 14's (in Alu-PVC clear film blisters)	White colored round uncoated tablets with bevel edges and marked with AM/5 on one side, plain on the other side	28/01/2021
A4-2327	Tablet	Amedin 10 mg Tablets TAB 10 mg 2 x 14's (in Alu-PVC clear film blisters)	White colored round uncoated tablets marked with AM/10 on one side and plain on the other side	28/01/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08CA01	Amlodipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	53727, 53728
NG	Registered Drug Product Database	A4-2110, A4-2327